Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$461M |
| 2 |
Deutsche Bank
DB
|
+$435M |
| 3 |
NVIDIA
NVDA
|
+$310M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$308M |
| 5 |
Sempra
SRE
|
+$298M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$791M |
| 2 |
Microsoft
MSFT
|
+$436M |
| 3 |
Zscaler
ZS
|
+$346M |
| 4 |
Bank of America
BAC
|
+$274M |
| 5 |
Broadcom
AVGO
|
+$268M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.04% |
| 2 | Financials | 13.18% |
| 3 | Healthcare | 10.51% |
| 4 | Communication Services | 9.68% |
| 5 | Consumer Discretionary | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Viking Holdings
VIK
$47.4B
| $510K | ﹤0.01% |
9,563
+2,990
| +45% | +$132K |
|
2377
Insteel Industries
IIIN
$603M
| $509K | ﹤0.01% |
13,691
-2,041
| -13% | -$68.1K |
|
2378
SI-BONE Inc
SIBN
$815M
| $509K | ﹤0.01% |
27,060
-5,523
| -17% | -$91.6K |
|
2379
Spyre Therapeutics
SYRE
$8.25B
| $508K | ﹤0.01% |
33,938
+5,455
| +19% | +$80.7K |
|
2380
REX American Resources
REX
$1.42B
| $508K | ﹤0.01% |
20,846
-8,266
| -28% | -$174K |
|
2381
i3 Verticals
IIIV
$418M
| $506K | ﹤0.01% |
18,414
-3,193
| -15% | -$80.1K |
|
2382
Capitol Federal Financial
CFFN
$1.12B
| $506K | ﹤0.01% |
82,874
-17,829
| -18% | -$101K |
|
2383
Liquidia Corp
LQDA
$7.42B
| $503K | ﹤0.01% |
40,386
-5,284
| -12% | -$78.2K |
|
2384
SITE Centers
SITC
$176M
| $502K | ﹤0.01% |
44,389
-16,966
| -28% | -$203K |
|
2385
Transcat
TRNS
$832M
| $502K | ﹤0.01% |
5,837
-1,392
| -19% | -$114K |
|
2386
Immunome
IMNM
$2.58B
| $500K | ﹤0.01% |
53,742
-9,940
| -16% | -$81.5K |
|
2387
Orrstown Financial Services
ORRF
$857M
| $499K | ﹤0.01% |
15,690
| – | – |
|
|
JHG
2388
DELISTED
Janus Henderson
JHG
| $498K | ﹤0.01% |
12,831
-340,140
| -96% | -$12M |
|
2389
First Mid Bancshares
FMBH
$1.41B
| $497K | ﹤0.01% |
13,250
-3,652
| -22% | -$128K |
|
2390
Pharvaris
PHVS
$2.25B
| $496K | ﹤0.01% |
28,186
+12
| +0% | +$193 |
|
2391
Deluxe
DLX
$1.23B
| $493K | ﹤0.01% |
30,984
-4,075
| -12% | -$61.4K |
|
2392
CAVA Group
CAVA
$7.54B
| $488K | ﹤0.01% |
5,794
-67,285
| -92% | -$5.74M |
|
|
NAGE
2393
Niagen Bioscience
NAGE
$276M
| $487K | ﹤0.01% |
33,830
+12,204
| +56% | +$121K |
|
2394
Lifestance Health
LFST
$4.05B
| $486K | ﹤0.01% |
94,011
-14,515
| -13% | -$87K |
|
2395
NewMarket
NEU
$7.82B
| $484K | ﹤0.01% |
701
-120
| -15% | -$74.5K |
|
2396
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.4B
| $484K | ﹤0.01% |
3,603
-686
| -16% | -$84.6K |
|
|
RYZ
2397
Ryerson Holding Corp
RYZ
$1.48B
| $482K | ﹤0.01% |
22,324
-133
| -0.6% | -$2.87K |
|
2398
FIGS
FIGS
$1.86B
| $480K | ﹤0.01% |
85,065
-167,306
| -66% | -$772K |
|
2399
Independent Bank Corp
IBCP
$797M
| $480K | ﹤0.01% |
14,801
+784
| +6% | +$24.3K |
|
|
PLYM
2400
DELISTED
Plymouth Industrial REIT
PLYM
| $480K | ﹤0.01% |
29,860
-6,940
| -19% | -$108K |
|
Similar funds
Deutsche Bank's Q2 2025 Portfolio in Review
As of Q2 2025, Deutsche Bank held 3,800 positions worth $272B, up 7.6% from $252B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Deutsche Bank's Q2 2025 filing shows 197 new, 1,017 increased, 1,982 reduced and 197 closed positions. Its largest new stake was Amrize Ltd: 4,354,301 shares worth $216M. The largest sale was UnitedHealth, an estimated $791M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- Deutsche Bank's largest Q2 2025 buy was Amrize Ltd: 4,354,301 shares worth $216M.
- Deutsche Bank added most to Apple in Q2 2025, an estimated $461M increase.
- Deutsche Bank's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $791M.
- Deutsche Bank fully exited Discover Financial Services in Q2 2025, selling an estimated $189M.
- Deutsche Bank's ten largest holdings make up 27% of its $272B portfolio in Q2 2025.
- Deutsche Bank opened 197 new positions and closed 197 in Q2 2025.
- Deutsche Bank's portfolio value rose 7.6% quarter-over-quarter to $272B.
Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.